{"gene":"LTBP4","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":1998,"finding":"LTBP-4 was identified as a novel member of the LTBP family, cloned from human heart cDNA. It is secreted from cultured human lung fibroblasts both as a free form and in a disulfide-bonded complex with a TGF-beta LAP-like protein, and both forms are deposited into the extracellular matrix. Matrix-associated LTBP-4 is susceptible to proteolytic release by plasmin.","method":"cDNA cloning, immunoblotting, ECM fractionation, plasmin treatment assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical characterization (disulfide complex, ECM deposition, plasmin cleavage) with multiple orthogonal methods in the founding paper","pmids":["9660815"],"is_preprint":false},{"year":1997,"finding":"LTBP-4 is a 1587-residue extracellular protein containing 20 EGF-like modules (17 with calcium-binding consensus) and 4 TB (8-cysteine) modules, predicting microfibrillar structure and TGF-beta binding capacity. Highly expressed in heart with presence in skeletal muscle, pancreas, placenta and lung.","method":"cDNA sequencing, Northern blot analysis","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — sequence-based domain architecture confirmed by Northern blot; foundational structural characterization but no functional reconstitution","pmids":["9271198"],"is_preprint":false},{"year":2001,"finding":"A novel alternatively spliced form of LTBP-4 lacking the 3rd 8-Cys repeat (LTBP-4Δ8-Cys3rd) was identified; this splice variant does not bind TGF-beta, providing a mechanism by which cells can decrease TGF-beta deposition without altering total LTBP-4 expression.","method":"RT-PCR, functional TGF-beta binding assay, exon-intron structure analysis","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding assay demonstrating loss of TGF-beta association with mutant isoform, single lab","pmids":["11683420"],"is_preprint":false},{"year":2002,"finding":"Disruption of LTBP-4 in mice causes pulmonary emphysema, cardiomyopathy, and colorectal cancer, associated with defective elastic fiber structure and reduced TGF-beta deposition in the ECM. Epithelial cells from knockout mice show reduced phospho-Smad2, overexpressed c-myc, and uncontrolled proliferation, establishing LTBP-4 as both an ECM structural component and a local regulator of TGF-beta signaling.","method":"Gene trap knockout mouse model, histology, immunohistochemistry, phospho-Smad2 western blot, c-myc expression analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with defined cellular and molecular phenotypes, multiple orthogonal readouts, widely replicated","pmids":["12208849"],"is_preprint":false},{"year":2004,"finding":"LTBP-4 deficiency in mouse lung fibroblasts impairs TGF-beta activation (not secretion), leading to compensatory upregulation of TGF-beta2 and -beta3. Loss of LTBP-4-mediated TGF-beta1 activation secondarily enhances BMP-4 signaling by reducing gremlin expression. Transfection of LTBP-4 rescued the knockout fibroblast phenotype; LTBP-1 was ineffective, and treatment with active TGF-beta1 normalized BMP-4 and gremlin expression.","method":"Knockout fibroblast analysis, microarray, active TGF-beta assay, rescue transfection, TGF-beta1 treatment","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including rescue transfection and ligand rescue, establishes pathway position","pmids":["15466481"],"is_preprint":false},{"year":2008,"finding":"LTBP-4 binds directly to fibronectin (FN) through its N-terminal region, and this interaction is indispensable for matrix assembly of LTBP-4. LTBP-4 also has heparin-binding activity in its N-terminal region, and heparin reduces both FN binding and cell adhesion mediated by LTBP-4's C-terminal domain. In FN-null fibroblasts, LTBP-4-mediated ECM targeting is disrupted, resulting in increased TGF-beta activity.","method":"Direct binding assays (LTBP-4 to FN), heparin competition assay, FN-null fibroblast analysis, fibroblast adhesion assay, immunofluorescence co-localization","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding demonstrated, FN-null cell model confirms functional consequence, multiple orthogonal methods","pmids":["18585707"],"is_preprint":false},{"year":2009,"finding":"LTBP-4S null mice show defects in elastogenesis visible from E14.5 onward, and air-sac septation defects associated with excessive TGF-beta signaling reversed by lowering TGF-beta2 levels; however, reversal of septation defects was not associated with normalization of elastogenesis, establishing two separate, independent functions of LTBP-4: regulation of elastic fiber assembly and modulation of TGF-beta levels.","method":"Ltbp4S-/- mouse model, histology, TGF-beta2 siRNA knockdown, pSmad analysis, time-course analysis E14.5–P7","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic dissection with TGF-beta2 knockdown, dual independent phenotypes separated, replicated findings","pmids":["19016471"],"is_preprint":false},{"year":2009,"finding":"Recessive loss-of-function mutations in LTBP4 in humans cause impaired synthesis and failure of LTBP4 deposition into the ECM, resulting in increased TGF-beta activity in cultured fibroblasts and defective elastic fiber assembly across multiple organ systems, establishing LTBP4 as essential for coupling TGF-beta signaling and ECM assembly in human development.","method":"Patient fibroblast analysis, LTBP4 ECM deposition assay, TGF-beta activity assay, mRNA stability analysis, Sanger sequencing","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — patient-derived cells with multiple orthogonal functional assays, multiple independent patients","pmids":["19836010"],"is_preprint":false},{"year":2010,"finding":"LTBP-4L and LTBP-4S are expressed from two independent promoters with distinct tissue-specific patterns. During secretion, LTBP-4L forms a complex with TGF-beta1 while LTBP-4S is secreted predominantly in free form. LTBP-4S is incorporated into the ECM while full-length LTBP-4L is not readily detectable in the ECM, establishing isoform-specific differences in TGF-beta complexing and ECM targeting.","method":"Promoter analysis, RT-PCR, western blot of conditioned medium and ECM fractions, immunofluorescence","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (promoter analysis, fractionation, immunoblot) establishing isoform-specific processing","pmids":["20175115"],"is_preprint":false},{"year":2013,"finding":"The IAAM haplotype of LTBP4 (SNPs V194I, T787A, T820A, T1140M) is associated with prolonged ambulation in DMD patients. Fibroblasts from IAAM individuals show reduced phospho-SMAD signaling in response to TGF-beta compared to VTTT fibroblasts, consistent with LTBP4 as a regulator of TGF-beta bioavailability.","method":"SNP haplotype analysis in patient cohort, TGF-beta stimulation assay with phospho-SMAD western blot in patient fibroblasts","journal":"Annals of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional fibroblast assay links haplotype to reduced TGF-beta signaling, single lab but replicated genotype association","pmids":["23440719"],"is_preprint":false},{"year":2015,"finding":"Both Ltbp-4 isoforms are required for normal elastogenesis and postnatal survival; Ltbp4-/- (null) mice die postnatally with severely defective ECM. Fibulin-4 was identified as a novel interaction partner of both Ltbp-4 isoforms; Ltbp-4L expression is essential for incorporation of fibulin-4 into the ECM.","method":"Mouse germline knockout (Ltbp4S-/- vs Ltbp4-/-), co-immunoprecipitation/pulldown for fibulin-4 interaction, immunofluorescence of ECM deposition, comparative histology","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic models with defined molecular readout (fibulin-4 ECM incorporation), physical interaction demonstrated, isoform-specific loss of function","pmids":["25713297"],"is_preprint":false},{"year":2016,"finding":"LTBP4 induces Pdgfrβ signaling by inhibiting the antioxidant Nrf2/Keap1 pathway in a TGF-beta-dependent manner. In Ltbp4S-/- mice, loss of this pathway contributes to pulmonary emphysema.","method":"Ltbp4S-/- mouse model, gene expression analysis, pathway inhibition studies (Nrf2/Keap1), TGF-beta dependency assay","journal":"Matrix biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway epistasis established by TGF-beta dependency and pathway analysis, single lab","pmids":["27645114"],"is_preprint":false},{"year":2016,"finding":"Ltbp-4L and fibulin-4 functionally interact in vivo; Ltbp4S-/-;Fibulin-4R/R double-mutant mice show dramatically reduced lifespan and severely impaired elastogenesis compared to single mutants, establishing that Ltbp-4L and fibulin-4 act together as a crucial molecular requirement for survival and elastogenesis.","method":"Double-mutant mouse genetic epistasis (Ltbp4S-/-;Fibulin-4R/R), survival analysis, histological analysis of lung and aorta","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean in vivo genetic epistasis with quantitative phenotypic readouts, confirms physical interaction from PMID:25713297","pmids":["27585882"],"is_preprint":false},{"year":2017,"finding":"LTBP4 deficiency in Ltbp4-/- mouse lungs contributes to alveolar septation defects through three interacting mechanisms: (1) absence of intact elastic fiber network, (2) reduced angiogenesis, and (3) upregulation of TGF-beta activity resulting in profibrotic processes.","method":"Ltbp4-/- mouse lung analysis, vascular morphometry, TGF-beta activity assay, histology, immunohistochemistry","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockout mouse with multiple defined mechanistic readouts, single lab","pmids":["28684544"],"is_preprint":false},{"year":2018,"finding":"Pro-inflammatory Ly6C+ macrophages drive fibrosis in DMD via high LTBP4 expression leading to elevated latent-TGF-beta1 production. AMPK activation in macrophages decreases Ltbp4 expression, reduces latent-TGF-beta1, and consequently reduces fibrosis and improves muscle force. Fibro-adipogenic progenitors supply TGF-beta-activating enzymes that act downstream of LTBP4-bound latent TGF-beta1.","method":"Mouse macrophage isolation and co-culture, AMPK pharmacological activation, LTBP4 siRNA knockdown, collagen assay, TGF-beta ELISA, muscle force measurement","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (knockdown, pharmacological activation, in vivo rescue) with defined molecular and functional readouts","pmids":["30463013"],"is_preprint":false},{"year":2019,"finding":"Fibulin-4 acts as a molecular extracellular chaperone for LTBP-4L: fibulin-4 multimers (not monomers) induce a conformational switch in LTBP-4L from compact to elongated structure, enhancing LTBP-4L binding to fibronectin and fibrillin-1 and promoting its matrix assembly. This elongated LTBP-4L conformation promotes elastogenesis but only when fibulin-4 is present to escort tropoelastin.","method":"Biophysical analysis (SEC-MALS, SAXS), binding assays (Co-IP, pulldown), tropoelastin assembly assay, fibulin-4 monomer vs multimer comparison, cell-free reconstitution","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with multiple orthogonal biophysical and biochemical methods, mechanistic detail of conformational switch with functional validation","pmids":["31548410"],"is_preprint":false},{"year":2021,"finding":"LTBP4 protects against renal tubular interstitial fibrosis (TIF) in a UUO mouse model; Ltbp4S-/- mice show aggravated TIF. Overexpression of LTBP4 in human proximal tubule cells upregulates angiogenic pathways and VEGFA, preserves mitochondrial respiratory function, and the conditioned medium stimulates angiogenesis via upregulated VEGFRs in endothelial cells.","method":"UUO mouse model with Ltbp4S-/- mice, LTBP4 overexpression in HK-2 cells, transcriptomics, tube formation assay, mitochondrial respiration assay (Seahorse), VEGFA/VEGFR analysis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays in vitro and in vivo, novel function outside canonical TGF-beta role, single lab","pmids":["34645813"],"is_preprint":false},{"year":2021,"finding":"Aberrant interaction between mutated ADAMTSL2 and LTBP4 variant pairs upregulates TGF-beta signaling in human fibroblasts. The ADAMTSL2-LTBP4 interaction was confirmed, and specific AIS-associated variant pairs disrupt this interaction.","method":"Co-immunoprecipitation in human fibroblasts, TGF-beta signaling assay, exome variant analysis","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP of endogenous proteins with functional TGF-beta readout, single lab","pmids":["34958866"],"is_preprint":false},{"year":2022,"finding":"In melanoma cells, LTBP4 overexpression activates the Hippo signaling pathway (increased YAP1 phosphorylation, MST1 phosphorylation, MOB1 phosphorylation, and nuclear-to-cytoplasmic YAP1 translocation). LTBP4 loss increases the percentage of active TGF-beta1 secreted, and active TGF-beta1 inhibits Hippo-YAP1 signaling. Effects of LTBP4 overexpression on proliferation and metastasis were reversed by YAP1 or MST1 overexpression, establishing a LTBP4-TGF-beta1-Hippo-YAP1 axis.","method":"LTBP4 overexpression/knockdown in melanoma cells, Western blot, immunofluorescence, luciferase reporter assay, nude mouse xenograft, FACS","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cellular assays with rescue experiments defining pathway epistasis, single lab","pmids":["35252214"],"is_preprint":false},{"year":2022,"finding":"YAP overexpression in vascular smooth muscle cells (VSMCs) upregulates LTBP4 expression. LTBP4 promotes elastic fiber assembly in VSMCs. Silencing LTBP4 in VSMCs abolished the protective role of YAP overexpression against abdominal aortic aneurysm formation in vivo.","method":"VSMC-specific YAP overexpression mouse model, LTBP4 siRNA in VSMCs, in vivo AAA model, elastin staining, histology","journal":"Journal of cardiovascular translational research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo silencing epistasis experiment with defined phenotypic readout, single lab","pmids":["35708897"],"is_preprint":false},{"year":2023,"finding":"LTBP4 deficiency in mice (Ltbp4 knockdown) increases AKI severity and promotes transition to chronic kidney disease; knockout increases mitochondrial fragmentation (DRP1-dependent), reduces ATP production, decreases mitochondrial respiration and glycolysis. LTBP4-knockdown conditioned media reduces angiogenesis in endothelial cells. DRP1 inhibition with Mdivi-1 ameliorated inflammation and fibrosis in Ltbp4-knockdown mice.","method":"Ltbp4-knockdown mouse model (ischemia-reperfusion injury), HK-2 LTBP4 knockdown, Seahorse metabolic assay, tube formation assay, DRP1 inhibitor rescue experiment, electron microscopy of mitochondria","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods in vitro and in vivo with pharmacological rescue, single lab","pmids":["37232163"],"is_preprint":false},{"year":2025,"finding":"N-linked glycans of LTBP-4L (but not fibulin-4) are critical for fibulin-4-mediated conformational extension of LTBP-4L, impacting its function and assembly. Fibulin-5 strongly interacts with LTBP-4S (not LTBP-4L) and robustly induces conformational extension of LTBP-4S, enhancing fibronectin binding, LTBP-4S ECM deposition, and elastic fiber formation. N-linked glycans of fibulin-5 (but not LTBP-4S) are required for this interaction. Together LTBP-4L/fibulin-4 and LTBP-4S/fibulin-5 axes act synergistically in elastogenesis.","method":"Glycoproteomic analysis, enzymatic/recombinant deglycosylation, biophysical binding assays, LTBP-4S/fibulin-5 conformational extension assay, in vitro elastic fiber assembly assay, fibronectin binding assay","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with multiple orthogonal biophysical and biochemical methods, mechanistic dissection of N-glycan roles, dual-axis framework","pmids":["40608550"],"is_preprint":false},{"year":2026,"finding":"In cardiomyocytes, LTBP4 is recruited to the microtubule-organizing center (MTOC) via dynein following angiotensin II stimulation. LTBP4 then facilitates dynein-mediated NLRP3 translocation to the MTOC and promotes NLRP3-NEK7 interaction, thereby driving NLRP3 inflammasome activation. Cardiomyocyte-specific Ltbp4 deficiency attenuates NLRP3 inflammasome activation, cardiac dysfunction, and fibrosis after pressure overload. Pressure overload upregulates LTBP4 partially via the SP1 transcription factor.","method":"Cardiomyocyte-specific Ltbp4 conditional knockout mouse (TAC model), Co-IP (LTBP4-dynein, NLRP3-NEK7), immunofluorescence (MTOC localization), SP1 transcription factor analysis, NLRP3 inflammasome activity assays, cardiac function echocardiography","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with defined molecular mechanism, Co-IP of complex components, localization with functional consequence, multiple orthogonal methods","pmids":["42140931"],"is_preprint":false}],"current_model":"LTBP4 is a multifunctional extracellular matrix protein that (1) sequesters latent TGF-beta in the ECM via covalent disulfide bonding through its 3rd 8-cysteine domain, enabling targeted TGF-beta activation and Smad-dependent signaling; (2) serves as a structural scaffold for elastic fiber assembly by adopting a compact conformation that is switched to an extended form by fibulin-4 multimers (for LTBP-4L) or fibulin-5 (for LTBP-4S), with N-glycans playing isoform-specific regulatory roles; (3) targets to the ECM via direct fibronectin binding at its N-terminal region (with fibulin-4-dependent fibulin-1 and fibrillin-1 interactions following conformational extension); and (4) in cardiomyocytes, translocates intracellularly to the MTOC via dynein, where it facilitates NLRP3-NEK7 interaction to drive NLRP3 inflammasome activation."},"narrative":{"mechanistic_narrative":"LTBP4 is a secreted extracellular matrix glycoprotein that couples latent TGF-beta sequestration to elastic fiber assembly, functioning as both a structural ECM component and a local regulator of TGF-beta bioavailability [PMID:9660815, PMID:12208849]. It is secreted both free and as a disulfide-bonded complex with a TGF-beta LAP-like protein, with TGF-beta binding mediated by its third 8-cysteine (TB) module; an alternatively spliced variant lacking this module fails to bind TGF-beta, allowing cells to tune TGF-beta deposition independent of total expression [PMID:9660815, PMID:11683420]. ECM targeting depends on direct binding of the LTBP-4 N-terminal region to fibronectin, and loss of this targeting elevates TGF-beta activity [PMID:18585707]. Genetic ablation in mice produces pulmonary emphysema, cardiomyopathy, and colorectal cancer with defective elastic fibers and reduced ECM TGF-beta deposition, where LTBP4 specifically enables TGF-beta1 activation (rather than secretion) and thereby restrains compensatory TGF-beta2/beta3 upregulation and BMP-4 signaling [PMID:12208849, PMID:15466481]; recessive loss-of-function mutations cause an analogous human disorder of failed ECM deposition, increased TGF-beta activity, and multi-organ elastic fiber defects [PMID:19836010]. LTBP4's structural and TGF-beta-regulatory roles are genetically separable [PMID:19016471]. The two isoforms generated from independent promoters are functionally distinct: LTBP-4L complexes with TGF-beta1 and is required for fibulin-4 incorporation into the matrix, whereas LTBP-4S is secreted largely free and is incorporated into the ECM [PMID:20175115, PMID:25713297]. Fibulin-4 multimers act as an extracellular chaperone, switching LTBP-4L from a compact to an elongated conformation that enhances fibronectin and fibrillin-1 binding and drives elastogenesis, while fibulin-5 performs the analogous conformational switch on LTBP-4S; N-linked glycans confer isoform-specific control of these axes, which act synergistically [PMID:31548410, PMID:40608550]. Beyond the matrix, LTBP4 has context-specific signaling roles, including a cardiomyocyte function in which it is recruited to the MTOC via dynein after angiotensin II stimulation to facilitate NLRP3-NEK7 interaction and inflammasome activation [PMID:42140931].","teleology":[{"year":1998,"claim":"Establishing LTBP4's basic biochemistry answered whether it physically links TGF-beta to the ECM: it does, via a disulfide-bonded latent complex deposited into matrix and releasable by proteolysis.","evidence":"cDNA cloning, immunoblotting, ECM fractionation, and plasmin treatment of human lung fibroblast secretions","pmids":["9660815"],"confidence":"High","gaps":["Identity of the activating protease(s) in vivo not defined","Domain mediating TGF-beta complexing not yet mapped"]},{"year":1997,"claim":"Domain architecture clarified the structural basis for both functions, predicting microfibrillar/elastic roles and TGF-beta binding capacity.","evidence":"cDNA sequencing and Northern blot defining 20 EGF-like and 4 TB modules and tissue expression","pmids":["9271198"],"confidence":"Medium","gaps":["No functional reconstitution of predicted activities","Which TB module binds TGF-beta not resolved"]},{"year":2001,"claim":"Mapping TGF-beta binding to the third 8-Cys module showed how alternative splicing can decouple TGF-beta sequestration from total LTBP4 levels.","evidence":"RT-PCR identification of a splice variant and functional TGF-beta binding assay","pmids":["11683420"],"confidence":"Medium","gaps":["Physiological prevalence and regulation of the splice variant unknown","Single lab"]},{"year":2002,"claim":"Knockout phenotyping established LTBP4 as both an ECM structural component and a local restraint on TGF-beta signaling, linking its loss to emphysema, cardiomyopathy, and cancer.","evidence":"Gene-trap knockout mouse with histology, phospho-Smad2, and c-myc analyses","pmids":["12208849"],"confidence":"High","gaps":["Whether structural vs signaling defects are separable not addressed here","Mechanism of TGF-beta regulation (activation vs deposition) unresolved"]},{"year":2004,"claim":"Defining the step LTBP4 controls showed it is required for TGF-beta1 activation, not secretion, with downstream consequences for compensatory TGF-beta isoforms and BMP-4 signaling.","evidence":"Knockout fibroblast microarray, active TGF-beta assay, rescue transfection, and ligand rescue","pmids":["15466481"],"confidence":"High","gaps":["Molecular mechanism by which LTBP4 enables activation not defined","LTBP-1 non-redundancy mechanism unclear"]},{"year":2008,"claim":"Identifying fibronectin as the ECM-targeting receptor explained how LTBP4 reaches the matrix and how mistargeting elevates TGF-beta activity.","evidence":"Direct binding assays, heparin competition, and FN-null fibroblast analysis","pmids":["18585707"],"confidence":"High","gaps":["Heparin/proteoglycan partner identity in vivo unknown","Relationship to fibrillin microfibrils not yet mapped"]},{"year":2009,"claim":"Genetic dissection separated LTBP4's two roles, showing elastogenesis and TGF-beta modulation are independent functions; parallel human mutation studies confirmed both functions in human development.","evidence":"Ltbp4S-/- mice with TGF-beta2 knockdown and time-course analysis; patient fibroblast ECM deposition and TGF-beta activity assays","pmids":["19016471","19836010"],"confidence":"High","gaps":["Molecular basis distinguishing the two functions not resolved","Spectrum of human phenotypes incompletely defined"]},{"year":2010,"claim":"Resolving isoform behavior showed LTBP-4L and LTBP-4S differ in TGF-beta complexing and ECM targeting, arising from independent promoters.","evidence":"Promoter analysis, conditioned-medium/ECM fractionation, and immunofluorescence","pmids":["20175115"],"confidence":"High","gaps":["Why LTBP-4L is poorly matrix-incorporated alone unexplained at this stage","Tissue-specific functional division of labor untested"]},{"year":2015,"claim":"Identifying fibulin-4 as a partner of both isoforms, with LTBP-4L required for fibulin-4 matrix incorporation, linked LTBP4 to a specific elastogenic assembly node.","evidence":"Germline knockout comparison, Co-IP/pulldown, and ECM immunofluorescence","pmids":["25713297"],"confidence":"High","gaps":["Mechanism of fibulin-4 incorporation dependence unknown","Structural basis of interaction not defined"]},{"year":2016,"claim":"In vivo epistasis confirmed LTBP-4L and fibulin-4 act together as a requirement for survival and elastogenesis, and additional work tied LTBP4 to Nrf2/Keap1-PdgfrB regulation downstream of TGF-beta.","evidence":"Ltbp4S-/-;Fibulin-4R/R double mutants; Ltbp4S-/- pathway analysis with TGF-beta dependency","pmids":["27585882","27645114"],"confidence":"High","gaps":["Nrf2/Keap1 link is single-lab and mechanistically indirect","How the LTBP-4L/fibulin-4 partnership executes elastogenesis still molecular-level open"]},{"year":2017,"claim":"Mechanistic deconstruction of the lung phenotype showed septation defects arise from combined loss of elastic fibers, reduced angiogenesis, and excess TGF-beta-driven fibrosis.","evidence":"Ltbp4-/- lung morphometry, vascular analysis, TGF-beta activity assays","pmids":["28684544"],"confidence":"Medium","gaps":["Relative contribution of each mechanism not quantified","Single lab"]},{"year":2019,"claim":"Reconstitution revealed the molecular mechanism of fibulin-4 action: as multimers it chaperones a compact-to-elongated conformational switch in LTBP-4L that enables matrix protein binding and elastogenesis.","evidence":"SEC-MALS, SAXS, Co-IP/pulldown, and cell-free tropoelastin assembly assays","pmids":["31548410"],"confidence":"High","gaps":["In vivo timing of the conformational switch not visualized","Whether LTBP-4S uses an analogous mechanism not yet tested"]},{"year":2025,"claim":"Completing the dual-axis model, fibulin-5 was shown to drive an analogous conformational extension of LTBP-4S, with N-glycans conferring isoform-specific control of both axes.","evidence":"Glycoproteomics, deglycosylation, biophysical binding, and in vitro elastic fiber assembly assays","pmids":["40608550"],"confidence":"High","gaps":["In vivo synergy of the two axes not genetically tested","Glycosyltransferases responsible not identified"]},{"year":2026,"claim":"A non-canonical intracellular role was defined: LTBP4 is recruited to the MTOC via dynein and facilitates NLRP3-NEK7 inflammasome assembly in stressed cardiomyocytes.","evidence":"Cardiomyocyte-specific conditional knockout (TAC), Co-IP, MTOC immunofluorescence, and inflammasome activity assays","pmids":["42140931"],"confidence":"High","gaps":["How a secreted ECM protein accesses the cytoplasmic MTOC pool not explained","Generality beyond cardiomyocytes untested"]},{"year":null,"claim":"How LTBP4's canonical extracellular elastogenic/TGF-beta functions mechanistically relate to its emerging intracellular and tissue-protective signaling roles (Hippo-YAP, renal mitochondrial/angiogenic, inflammasome) remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying mechanism connecting extracellular and intracellular pools","Many context-specific signaling roles rest on single-lab studies","Trafficking that diverts secreted LTBP4 to intracellular compartments undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[0,2,8]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[3,6,10,15]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,7]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[5]}],"localization":[{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[0,5,8,10]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,7]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[22]}],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[5,7,10,15,21]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4,9]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[14,22]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,7]}],"complexes":["LTBP4-latent TGF-beta complex"],"partners":["TGFB1","FN1","FBLN4","FBLN5","FBN1","ADAMTSL2","DYNC1H1","NLRP3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8N2S1","full_name":"Latent-transforming growth factor beta-binding protein 4","aliases":[],"length_aa":1624,"mass_kda":173.4,"function":"Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space. Associates specifically via disulfide bonds with the Latency-associated peptide (LAP), which is the regulatory chain of TGF-beta, and regulates integrin-dependent activation of TGF-beta","subcellular_location":"Secreted, extracellular space, extracellular matrix","url":"https://www.uniprot.org/uniprotkb/Q8N2S1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/LTBP4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":74,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/LTBP4","total_profiled":1310},"omim":[{"mim_id":"613177","title":"CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C","url":"https://www.omim.org/entry/613177"},{"mim_id":"604710","title":"LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 4; LTBP4","url":"https://www.omim.org/entry/604710"},{"mim_id":"604580","title":"FIBULIN 5; FBLN5","url":"https://www.omim.org/entry/604580"},{"mim_id":"602194","title":"HTRA SERINE PEPTIDASE 1; HTRA1","url":"https://www.omim.org/entry/602194"},{"mim_id":"600142","title":"CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY 2; CARASIL2","url":"https://www.omim.org/entry/600142"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"blood vessel","ntpm":548.8}],"url":"https://www.proteinatlas.org/search/LTBP4"},"hgnc":{"alias_symbol":["LTBP-4","LTBP-4L","FLJ46318","FLJ90018"],"prev_symbol":[]},"alphafold":{"accession":"Q8N2S1","domains":[{"cath_id":"-","chopping":"286-325","consensus_level":"medium","plddt":78.4613,"start":286,"end":325},{"cath_id":"2.10.25.10","chopping":"355-402","consensus_level":"medium","plddt":73.794,"start":355,"end":402},{"cath_id":"3.90.290.10","chopping":"410-474","consensus_level":"medium","plddt":77.6711,"start":410,"end":474},{"cath_id":"-","chopping":"768-879","consensus_level":"medium","plddt":74.8611,"start":768,"end":879},{"cath_id":"2.10.25.10","chopping":"882-922","consensus_level":"medium","plddt":74.4085,"start":882,"end":922},{"cath_id":"-","chopping":"970-1006","consensus_level":"medium","plddt":71.6995,"start":970,"end":1006},{"cath_id":"-","chopping":"1093-1128","consensus_level":"medium","plddt":77.9158,"start":1093,"end":1128},{"cath_id":"3.90.290.10","chopping":"1311-1403","consensus_level":"medium","plddt":74.0032,"start":1311,"end":1403},{"cath_id":"2.10.25.10","chopping":"1531-1576","consensus_level":"medium","plddt":73.9213,"start":1531,"end":1576},{"cath_id":"2.10.25.10","chopping":"1586-1624","consensus_level":"medium","plddt":78.9669,"start":1586,"end":1624}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N2S1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N2S1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N2S1-F1-predicted_aligned_error_v6.png","plddt_mean":62.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LTBP4","jax_strain_url":"https://www.jax.org/strain/search?query=LTBP4"},"sequence":{"accession":"Q8N2S1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8N2S1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8N2S1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N2S1"}},"corpus_meta":[{"pmid":"12208849","id":"PMC_12208849","title":"Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12208849","citation_count":207,"is_preprint":false},{"pmid":"23440719","id":"PMC_23440719","title":"LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy.","date":"2013","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23440719","citation_count":204,"is_preprint":false},{"pmid":"30463013","id":"PMC_30463013","title":"AMPK Activation Regulates LTBP4-Dependent TGF-β1 Secretion by Pro-inflammatory Macrophages and Controls Fibrosis in Duchenne Muscular Dystrophy.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30463013","citation_count":181,"is_preprint":false},{"pmid":"19836010","id":"PMC_19836010","title":"Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19836010","citation_count":124,"is_preprint":false},{"pmid":"9660815","id":"PMC_9660815","title":"Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9660815","citation_count":113,"is_preprint":false},{"pmid":"25476005","id":"PMC_25476005","title":"Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants.","date":"2014","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25476005","citation_count":78,"is_preprint":false},{"pmid":"9271198","id":"PMC_9271198","title":"Sequence and expression of a novel member (LTBP-4) of the family of latent transforming growth factor-beta binding proteins.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9271198","citation_count":65,"is_preprint":false},{"pmid":"15466481","id":"PMC_15466481","title":"Disruption of LTBP-4 function reduces TGF-beta activation and enhances BMP-4 signaling in the lung.","date":"2004","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15466481","citation_count":63,"is_preprint":false},{"pmid":"19016471","id":"PMC_19016471","title":"Dual functions for LTBP in lung development: LTBP-4 independently modulates elastogenesis and TGF-beta activity.","date":"2009","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19016471","citation_count":55,"is_preprint":false},{"pmid":"18585707","id":"PMC_18585707","title":"Fibronectin and heparin binding domains of latent TGF-beta binding protein (LTBP)-4 mediate matrix targeting and cell adhesion.","date":"2008","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/18585707","citation_count":55,"is_preprint":false},{"pmid":"30014611","id":"PMC_30014611","title":"Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in duchenne muscular dystrophy.","date":"2018","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/30014611","citation_count":43,"is_preprint":false},{"pmid":"25713297","id":"PMC_25713297","title":"Modeling autosomal recessive cutis laxa type 1C in mice reveals distinct functions for Ltbp-4 isoforms.","date":"2015","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/25713297","citation_count":40,"is_preprint":false},{"pmid":"34294164","id":"PMC_34294164","title":"The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene.","date":"2021","source":"Skeletal muscle","url":"https://pubmed.ncbi.nlm.nih.gov/34294164","citation_count":38,"is_preprint":false},{"pmid":"20375427","id":"PMC_20375427","title":"The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.","date":"2010","source":"Veterinary pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20375427","citation_count":38,"is_preprint":false},{"pmid":"34071145","id":"PMC_34071145","title":"LTBP4 in Health and Disease.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34071145","citation_count":35,"is_preprint":false},{"pmid":"29481844","id":"PMC_29481844","title":"Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.","date":"2018","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/29481844","citation_count":32,"is_preprint":false},{"pmid":"20175115","id":"PMC_20175115","title":"Independent regulation of short and long forms of latent TGF-beta binding protein (LTBP)-4 in cultured fibroblasts and human tissues.","date":"2010","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20175115","citation_count":32,"is_preprint":false},{"pmid":"31548410","id":"PMC_31548410","title":"Fibulin-4 exerts a dual role in LTBP-4L-mediated matrix assembly and function.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31548410","citation_count":29,"is_preprint":false},{"pmid":"11683420","id":"PMC_11683420","title":"Novel non-TGF-beta-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-beta deposition.","date":"2001","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/11683420","citation_count":24,"is_preprint":false},{"pmid":"37232163","id":"PMC_37232163","title":"LTBP4 Protects Against Renal Fibrosis via Mitochondrial and Vascular Impacts.","date":"2023","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/37232163","citation_count":23,"is_preprint":false},{"pmid":"27585882","id":"PMC_27585882","title":"Function of Ltbp-4L and fibulin-4 in survival and elastogenesis in mice.","date":"2016","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/27585882","citation_count":22,"is_preprint":false},{"pmid":"34645813","id":"PMC_34645813","title":"LTBP4 affects renal fibrosis by influencing angiogenesis and altering mitochondrial structure.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34645813","citation_count":22,"is_preprint":false},{"pmid":"21468687","id":"PMC_21468687","title":"Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas.","date":"2011","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/21468687","citation_count":21,"is_preprint":false},{"pmid":"28684544","id":"PMC_28684544","title":"Role of LTBP4 in alveolarization, angiogenesis, and fibrosis in lungs.","date":"2017","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28684544","citation_count":18,"is_preprint":false},{"pmid":"17550376","id":"PMC_17550376","title":"Latent transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary adenocarcinomas in vitro and in vivo.","date":"2007","source":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/17550376","citation_count":18,"is_preprint":false},{"pmid":"19836277","id":"PMC_19836277","title":"Downregulation of transforming growth factor β (TGFβ) and latent TGFβ binding protein (LTBP)-4 expression in late stage canine mammary tumours.","date":"2009","source":"Veterinary journal (London, England : 1997)","url":"https://pubmed.ncbi.nlm.nih.gov/19836277","citation_count":16,"is_preprint":false},{"pmid":"35252214","id":"PMC_35252214","title":"Disruption of LTBP4 Inhibition-Induced TGFβ1 Activation Promoted Cell Proliferation and Metastasis in Skin Melanoma by Inhibiting the Activation of the Hippo-YAP1 Signaling Pathway.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35252214","citation_count":15,"is_preprint":false},{"pmid":"31115174","id":"PMC_31115174","title":"Clinical and molecular characterization of an 18-month-old infant with autosomal recessive cutis laxa type 1C due to a novel LTBP4 pathogenic variant, and literature review.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31115174","citation_count":11,"is_preprint":false},{"pmid":"27645114","id":"PMC_27645114","title":"Ltbp4 regulates Pdgfrβ expression via TGFβ-dependent modulation of Nrf2 transcription factor function.","date":"2016","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/27645114","citation_count":11,"is_preprint":false},{"pmid":"29766838","id":"PMC_29766838","title":"DMD mutation and LTBP4 haplotype do not predict onset of left ventricular dysfunction in Duchenne muscular dystrophy.","date":"2018","source":"Cardiology in the young","url":"https://pubmed.ncbi.nlm.nih.gov/29766838","citation_count":9,"is_preprint":false},{"pmid":"34958866","id":"PMC_34958866","title":"Aberrant interaction between mutated ADAMTSL2 and LTBP4 is associated with adolescent idiopathic scoliosis.","date":"2021","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/34958866","citation_count":9,"is_preprint":false},{"pmid":"36011296","id":"PMC_36011296","title":"LTBP4, SPP1, and CD40 Variants: Genetic Modifiers of Duchenne Muscular Dystrophy Analyzed in Serbian Patients.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36011296","citation_count":8,"is_preprint":false},{"pmid":"32764991","id":"PMC_32764991","title":"Disruption of LTBP4 Induced Activated TGFβ1, Immunosuppression Signal and Promoted Pulmonary Metastasis in Hepatocellular Carcinoma.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32764991","citation_count":8,"is_preprint":false},{"pmid":"33302946","id":"PMC_33302946","title":"Two novel compound heterozygous variants of LTBP4 in a Chinese infant with cutis laxa type IC and a review of the related literature.","date":"2020","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/33302946","citation_count":4,"is_preprint":false},{"pmid":"35708897","id":"PMC_35708897","title":"Specific Overexpression of YAP in Vascular Smooth Muscle Attenuated Abdominal Aortic Aneurysm Formation by Activating Elastic Fiber Assembly via LTBP4.","date":"2022","source":"Journal of cardiovascular translational research","url":"https://pubmed.ncbi.nlm.nih.gov/35708897","citation_count":4,"is_preprint":false},{"pmid":"35972031","id":"PMC_35972031","title":"First report of a short in-frame biallelic deletion removing part of the EGF-like domain calcium-binding motif in LTBP4 and causing autosomal recessive cutis laxa type 1C.","date":"2022","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/35972031","citation_count":3,"is_preprint":false},{"pmid":"35445908","id":"PMC_35445908","title":"Autosomal recessive cutis laxa type 1C with a homozygous LTBP4 splicing variant: a case report and update of literature.","date":"2022","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/35445908","citation_count":3,"is_preprint":false},{"pmid":"32341818","id":"PMC_32341818","title":"Identification of a Novel 19-bp Deletion Mutation in LTBP4 Using Exome Sequencing in Two Siblings with Autosomal Recessive Cutis Laxa Type 1C.","date":"2019","source":"Journal of pediatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32341818","citation_count":3,"is_preprint":false},{"pmid":"41076474","id":"PMC_41076474","title":"Deleterious variants in LTBP4 are associated with severe pediatric sepsis.","date":"2025","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/41076474","citation_count":2,"is_preprint":false},{"pmid":"38363615","id":"PMC_38363615","title":"The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy.","date":"2024","source":"Journal of neuromuscular diseases","url":"https://pubmed.ncbi.nlm.nih.gov/38363615","citation_count":2,"is_preprint":false},{"pmid":"39193795","id":"PMC_39193795","title":"Epigenetic identification of LTBP4 as a putative tumor suppressor in breast cancer.","date":"2024","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/39193795","citation_count":1,"is_preprint":false},{"pmid":"41194282","id":"PMC_41194282","title":"Constitutional epimutations in LTBP4, a component of the TGF-β signaling, and in BRCA1, as potential drivers of early-onset colorectal cancer.","date":"2025","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/41194282","citation_count":1,"is_preprint":false},{"pmid":"38547642","id":"PMC_38547642","title":"Novel indel variation of LTBP4 gene associates with risk of sudden cardiac death in Chinese populations with coronary artery disease.","date":"2024","source":"Legal medicine (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/38547642","citation_count":1,"is_preprint":false},{"pmid":"40608550","id":"PMC_40608550","title":"Impact of N-linked glycans on the dual short fibulin/LTBP-4 axes regulating elastogenesis.","date":"2025","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/40608550","citation_count":0,"is_preprint":false},{"pmid":"42140931","id":"PMC_42140931","title":"LTBP4 deficiency inhibits NLRP3 inflammasome activation in cardiomyocytes and attenuates heart failure in male mice.","date":"2026","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/42140931","citation_count":0,"is_preprint":false},{"pmid":"41388516","id":"PMC_41388516","title":"Fibulin-5 promotes fibroblast activation through LTBP-4 to improve the pathogenesis of hemorrhoids.","date":"2025","source":"BMC gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/41388516","citation_count":0,"is_preprint":false},{"pmid":"36524797","id":"PMC_36524797","title":"Association of polymorphisms rs2303729, rs10880, and rs1131620 of LTBP4 with sarcopenia in elderly patients with type 2 diabetes mellitus.","date":"2022","source":"Annals of human biology","url":"https://pubmed.ncbi.nlm.nih.gov/36524797","citation_count":0,"is_preprint":false},{"pmid":"42164084","id":"PMC_42164084","title":"Extracellular matrix remodeling in calcific aortic valve disease: Localized enrichment of type III collagen and LTBP-4.","date":"2026","source":"Matrix biology plus","url":"https://pubmed.ncbi.nlm.nih.gov/42164084","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.18.657655","title":"Fibulin-4 is highly expressed in metastatic breast cancer and can serve as a target of peptide-based imaging probes and experimental therapeutics","date":"2025-06-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.18.657655","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.21.666043","title":"The Tricuspid Valve is Transcriptionally Active During Prolonged Pressure Overload, Right-Sided Heart Failure, and Valve Regurgitation","date":"2025-07-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.21.666043","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.20.655139","title":"Validation of Duchenne muscular dystrophy candidate modifiers using a CRISPR-Cas9-based approach in zebrafish","date":"2025-05-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.20.655139","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.09.20.24314065","title":"Plasma proteomics reveals the potential causal impact of extracellular matrix proteins on abdominal aortic aneurysm","date":"2024-09-23","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.20.24314065","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":29754,"output_tokens":6376,"usd":0.092451,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15003,"output_tokens":4665,"usd":0.09582,"stage2_stop_reason":"end_turn"},"total_usd":0.188271,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"LTBP-4 was identified as a novel member of the LTBP family, cloned from human heart cDNA. It is secreted from cultured human lung fibroblasts both as a free form and in a disulfide-bonded complex with a TGF-beta LAP-like protein, and both forms are deposited into the extracellular matrix. Matrix-associated LTBP-4 is susceptible to proteolytic release by plasmin.\",\n      \"method\": \"cDNA cloning, immunoblotting, ECM fractionation, plasmin treatment assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical characterization (disulfide complex, ECM deposition, plasmin cleavage) with multiple orthogonal methods in the founding paper\",\n      \"pmids\": [\"9660815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"LTBP-4 is a 1587-residue extracellular protein containing 20 EGF-like modules (17 with calcium-binding consensus) and 4 TB (8-cysteine) modules, predicting microfibrillar structure and TGF-beta binding capacity. Highly expressed in heart with presence in skeletal muscle, pancreas, placenta and lung.\",\n      \"method\": \"cDNA sequencing, Northern blot analysis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — sequence-based domain architecture confirmed by Northern blot; foundational structural characterization but no functional reconstitution\",\n      \"pmids\": [\"9271198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A novel alternatively spliced form of LTBP-4 lacking the 3rd 8-Cys repeat (LTBP-4Δ8-Cys3rd) was identified; this splice variant does not bind TGF-beta, providing a mechanism by which cells can decrease TGF-beta deposition without altering total LTBP-4 expression.\",\n      \"method\": \"RT-PCR, functional TGF-beta binding assay, exon-intron structure analysis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assay demonstrating loss of TGF-beta association with mutant isoform, single lab\",\n      \"pmids\": [\"11683420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Disruption of LTBP-4 in mice causes pulmonary emphysema, cardiomyopathy, and colorectal cancer, associated with defective elastic fiber structure and reduced TGF-beta deposition in the ECM. Epithelial cells from knockout mice show reduced phospho-Smad2, overexpressed c-myc, and uncontrolled proliferation, establishing LTBP-4 as both an ECM structural component and a local regulator of TGF-beta signaling.\",\n      \"method\": \"Gene trap knockout mouse model, histology, immunohistochemistry, phospho-Smad2 western blot, c-myc expression analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with defined cellular and molecular phenotypes, multiple orthogonal readouts, widely replicated\",\n      \"pmids\": [\"12208849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"LTBP-4 deficiency in mouse lung fibroblasts impairs TGF-beta activation (not secretion), leading to compensatory upregulation of TGF-beta2 and -beta3. Loss of LTBP-4-mediated TGF-beta1 activation secondarily enhances BMP-4 signaling by reducing gremlin expression. Transfection of LTBP-4 rescued the knockout fibroblast phenotype; LTBP-1 was ineffective, and treatment with active TGF-beta1 normalized BMP-4 and gremlin expression.\",\n      \"method\": \"Knockout fibroblast analysis, microarray, active TGF-beta assay, rescue transfection, TGF-beta1 treatment\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including rescue transfection and ligand rescue, establishes pathway position\",\n      \"pmids\": [\"15466481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"LTBP-4 binds directly to fibronectin (FN) through its N-terminal region, and this interaction is indispensable for matrix assembly of LTBP-4. LTBP-4 also has heparin-binding activity in its N-terminal region, and heparin reduces both FN binding and cell adhesion mediated by LTBP-4's C-terminal domain. In FN-null fibroblasts, LTBP-4-mediated ECM targeting is disrupted, resulting in increased TGF-beta activity.\",\n      \"method\": \"Direct binding assays (LTBP-4 to FN), heparin competition assay, FN-null fibroblast analysis, fibroblast adhesion assay, immunofluorescence co-localization\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding demonstrated, FN-null cell model confirms functional consequence, multiple orthogonal methods\",\n      \"pmids\": [\"18585707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"LTBP-4S null mice show defects in elastogenesis visible from E14.5 onward, and air-sac septation defects associated with excessive TGF-beta signaling reversed by lowering TGF-beta2 levels; however, reversal of septation defects was not associated with normalization of elastogenesis, establishing two separate, independent functions of LTBP-4: regulation of elastic fiber assembly and modulation of TGF-beta levels.\",\n      \"method\": \"Ltbp4S-/- mouse model, histology, TGF-beta2 siRNA knockdown, pSmad analysis, time-course analysis E14.5–P7\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic dissection with TGF-beta2 knockdown, dual independent phenotypes separated, replicated findings\",\n      \"pmids\": [\"19016471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Recessive loss-of-function mutations in LTBP4 in humans cause impaired synthesis and failure of LTBP4 deposition into the ECM, resulting in increased TGF-beta activity in cultured fibroblasts and defective elastic fiber assembly across multiple organ systems, establishing LTBP4 as essential for coupling TGF-beta signaling and ECM assembly in human development.\",\n      \"method\": \"Patient fibroblast analysis, LTBP4 ECM deposition assay, TGF-beta activity assay, mRNA stability analysis, Sanger sequencing\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — patient-derived cells with multiple orthogonal functional assays, multiple independent patients\",\n      \"pmids\": [\"19836010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"LTBP-4L and LTBP-4S are expressed from two independent promoters with distinct tissue-specific patterns. During secretion, LTBP-4L forms a complex with TGF-beta1 while LTBP-4S is secreted predominantly in free form. LTBP-4S is incorporated into the ECM while full-length LTBP-4L is not readily detectable in the ECM, establishing isoform-specific differences in TGF-beta complexing and ECM targeting.\",\n      \"method\": \"Promoter analysis, RT-PCR, western blot of conditioned medium and ECM fractions, immunofluorescence\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (promoter analysis, fractionation, immunoblot) establishing isoform-specific processing\",\n      \"pmids\": [\"20175115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The IAAM haplotype of LTBP4 (SNPs V194I, T787A, T820A, T1140M) is associated with prolonged ambulation in DMD patients. Fibroblasts from IAAM individuals show reduced phospho-SMAD signaling in response to TGF-beta compared to VTTT fibroblasts, consistent with LTBP4 as a regulator of TGF-beta bioavailability.\",\n      \"method\": \"SNP haplotype analysis in patient cohort, TGF-beta stimulation assay with phospho-SMAD western blot in patient fibroblasts\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional fibroblast assay links haplotype to reduced TGF-beta signaling, single lab but replicated genotype association\",\n      \"pmids\": [\"23440719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Both Ltbp-4 isoforms are required for normal elastogenesis and postnatal survival; Ltbp4-/- (null) mice die postnatally with severely defective ECM. Fibulin-4 was identified as a novel interaction partner of both Ltbp-4 isoforms; Ltbp-4L expression is essential for incorporation of fibulin-4 into the ECM.\",\n      \"method\": \"Mouse germline knockout (Ltbp4S-/- vs Ltbp4-/-), co-immunoprecipitation/pulldown for fibulin-4 interaction, immunofluorescence of ECM deposition, comparative histology\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic models with defined molecular readout (fibulin-4 ECM incorporation), physical interaction demonstrated, isoform-specific loss of function\",\n      \"pmids\": [\"25713297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LTBP4 induces Pdgfrβ signaling by inhibiting the antioxidant Nrf2/Keap1 pathway in a TGF-beta-dependent manner. In Ltbp4S-/- mice, loss of this pathway contributes to pulmonary emphysema.\",\n      \"method\": \"Ltbp4S-/- mouse model, gene expression analysis, pathway inhibition studies (Nrf2/Keap1), TGF-beta dependency assay\",\n      \"journal\": \"Matrix biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway epistasis established by TGF-beta dependency and pathway analysis, single lab\",\n      \"pmids\": [\"27645114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Ltbp-4L and fibulin-4 functionally interact in vivo; Ltbp4S-/-;Fibulin-4R/R double-mutant mice show dramatically reduced lifespan and severely impaired elastogenesis compared to single mutants, establishing that Ltbp-4L and fibulin-4 act together as a crucial molecular requirement for survival and elastogenesis.\",\n      \"method\": \"Double-mutant mouse genetic epistasis (Ltbp4S-/-;Fibulin-4R/R), survival analysis, histological analysis of lung and aorta\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean in vivo genetic epistasis with quantitative phenotypic readouts, confirms physical interaction from PMID:25713297\",\n      \"pmids\": [\"27585882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LTBP4 deficiency in Ltbp4-/- mouse lungs contributes to alveolar septation defects through three interacting mechanisms: (1) absence of intact elastic fiber network, (2) reduced angiogenesis, and (3) upregulation of TGF-beta activity resulting in profibrotic processes.\",\n      \"method\": \"Ltbp4-/- mouse lung analysis, vascular morphometry, TGF-beta activity assay, histology, immunohistochemistry\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout mouse with multiple defined mechanistic readouts, single lab\",\n      \"pmids\": [\"28684544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Pro-inflammatory Ly6C+ macrophages drive fibrosis in DMD via high LTBP4 expression leading to elevated latent-TGF-beta1 production. AMPK activation in macrophages decreases Ltbp4 expression, reduces latent-TGF-beta1, and consequently reduces fibrosis and improves muscle force. Fibro-adipogenic progenitors supply TGF-beta-activating enzymes that act downstream of LTBP4-bound latent TGF-beta1.\",\n      \"method\": \"Mouse macrophage isolation and co-culture, AMPK pharmacological activation, LTBP4 siRNA knockdown, collagen assay, TGF-beta ELISA, muscle force measurement\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (knockdown, pharmacological activation, in vivo rescue) with defined molecular and functional readouts\",\n      \"pmids\": [\"30463013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Fibulin-4 acts as a molecular extracellular chaperone for LTBP-4L: fibulin-4 multimers (not monomers) induce a conformational switch in LTBP-4L from compact to elongated structure, enhancing LTBP-4L binding to fibronectin and fibrillin-1 and promoting its matrix assembly. This elongated LTBP-4L conformation promotes elastogenesis but only when fibulin-4 is present to escort tropoelastin.\",\n      \"method\": \"Biophysical analysis (SEC-MALS, SAXS), binding assays (Co-IP, pulldown), tropoelastin assembly assay, fibulin-4 monomer vs multimer comparison, cell-free reconstitution\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with multiple orthogonal biophysical and biochemical methods, mechanistic detail of conformational switch with functional validation\",\n      \"pmids\": [\"31548410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"LTBP4 protects against renal tubular interstitial fibrosis (TIF) in a UUO mouse model; Ltbp4S-/- mice show aggravated TIF. Overexpression of LTBP4 in human proximal tubule cells upregulates angiogenic pathways and VEGFA, preserves mitochondrial respiratory function, and the conditioned medium stimulates angiogenesis via upregulated VEGFRs in endothelial cells.\",\n      \"method\": \"UUO mouse model with Ltbp4S-/- mice, LTBP4 overexpression in HK-2 cells, transcriptomics, tube formation assay, mitochondrial respiration assay (Seahorse), VEGFA/VEGFR analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays in vitro and in vivo, novel function outside canonical TGF-beta role, single lab\",\n      \"pmids\": [\"34645813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Aberrant interaction between mutated ADAMTSL2 and LTBP4 variant pairs upregulates TGF-beta signaling in human fibroblasts. The ADAMTSL2-LTBP4 interaction was confirmed, and specific AIS-associated variant pairs disrupt this interaction.\",\n      \"method\": \"Co-immunoprecipitation in human fibroblasts, TGF-beta signaling assay, exome variant analysis\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP of endogenous proteins with functional TGF-beta readout, single lab\",\n      \"pmids\": [\"34958866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In melanoma cells, LTBP4 overexpression activates the Hippo signaling pathway (increased YAP1 phosphorylation, MST1 phosphorylation, MOB1 phosphorylation, and nuclear-to-cytoplasmic YAP1 translocation). LTBP4 loss increases the percentage of active TGF-beta1 secreted, and active TGF-beta1 inhibits Hippo-YAP1 signaling. Effects of LTBP4 overexpression on proliferation and metastasis were reversed by YAP1 or MST1 overexpression, establishing a LTBP4-TGF-beta1-Hippo-YAP1 axis.\",\n      \"method\": \"LTBP4 overexpression/knockdown in melanoma cells, Western blot, immunofluorescence, luciferase reporter assay, nude mouse xenograft, FACS\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cellular assays with rescue experiments defining pathway epistasis, single lab\",\n      \"pmids\": [\"35252214\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"YAP overexpression in vascular smooth muscle cells (VSMCs) upregulates LTBP4 expression. LTBP4 promotes elastic fiber assembly in VSMCs. Silencing LTBP4 in VSMCs abolished the protective role of YAP overexpression against abdominal aortic aneurysm formation in vivo.\",\n      \"method\": \"VSMC-specific YAP overexpression mouse model, LTBP4 siRNA in VSMCs, in vivo AAA model, elastin staining, histology\",\n      \"journal\": \"Journal of cardiovascular translational research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo silencing epistasis experiment with defined phenotypic readout, single lab\",\n      \"pmids\": [\"35708897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LTBP4 deficiency in mice (Ltbp4 knockdown) increases AKI severity and promotes transition to chronic kidney disease; knockout increases mitochondrial fragmentation (DRP1-dependent), reduces ATP production, decreases mitochondrial respiration and glycolysis. LTBP4-knockdown conditioned media reduces angiogenesis in endothelial cells. DRP1 inhibition with Mdivi-1 ameliorated inflammation and fibrosis in Ltbp4-knockdown mice.\",\n      \"method\": \"Ltbp4-knockdown mouse model (ischemia-reperfusion injury), HK-2 LTBP4 knockdown, Seahorse metabolic assay, tube formation assay, DRP1 inhibitor rescue experiment, electron microscopy of mitochondria\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods in vitro and in vivo with pharmacological rescue, single lab\",\n      \"pmids\": [\"37232163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"N-linked glycans of LTBP-4L (but not fibulin-4) are critical for fibulin-4-mediated conformational extension of LTBP-4L, impacting its function and assembly. Fibulin-5 strongly interacts with LTBP-4S (not LTBP-4L) and robustly induces conformational extension of LTBP-4S, enhancing fibronectin binding, LTBP-4S ECM deposition, and elastic fiber formation. N-linked glycans of fibulin-5 (but not LTBP-4S) are required for this interaction. Together LTBP-4L/fibulin-4 and LTBP-4S/fibulin-5 axes act synergistically in elastogenesis.\",\n      \"method\": \"Glycoproteomic analysis, enzymatic/recombinant deglycosylation, biophysical binding assays, LTBP-4S/fibulin-5 conformational extension assay, in vitro elastic fiber assembly assay, fibronectin binding assay\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with multiple orthogonal biophysical and biochemical methods, mechanistic dissection of N-glycan roles, dual-axis framework\",\n      \"pmids\": [\"40608550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In cardiomyocytes, LTBP4 is recruited to the microtubule-organizing center (MTOC) via dynein following angiotensin II stimulation. LTBP4 then facilitates dynein-mediated NLRP3 translocation to the MTOC and promotes NLRP3-NEK7 interaction, thereby driving NLRP3 inflammasome activation. Cardiomyocyte-specific Ltbp4 deficiency attenuates NLRP3 inflammasome activation, cardiac dysfunction, and fibrosis after pressure overload. Pressure overload upregulates LTBP4 partially via the SP1 transcription factor.\",\n      \"method\": \"Cardiomyocyte-specific Ltbp4 conditional knockout mouse (TAC model), Co-IP (LTBP4-dynein, NLRP3-NEK7), immunofluorescence (MTOC localization), SP1 transcription factor analysis, NLRP3 inflammasome activity assays, cardiac function echocardiography\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with defined molecular mechanism, Co-IP of complex components, localization with functional consequence, multiple orthogonal methods\",\n      \"pmids\": [\"42140931\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LTBP4 is a multifunctional extracellular matrix protein that (1) sequesters latent TGF-beta in the ECM via covalent disulfide bonding through its 3rd 8-cysteine domain, enabling targeted TGF-beta activation and Smad-dependent signaling; (2) serves as a structural scaffold for elastic fiber assembly by adopting a compact conformation that is switched to an extended form by fibulin-4 multimers (for LTBP-4L) or fibulin-5 (for LTBP-4S), with N-glycans playing isoform-specific regulatory roles; (3) targets to the ECM via direct fibronectin binding at its N-terminal region (with fibulin-4-dependent fibulin-1 and fibrillin-1 interactions following conformational extension); and (4) in cardiomyocytes, translocates intracellularly to the MTOC via dynein, where it facilitates NLRP3-NEK7 interaction to drive NLRP3 inflammasome activation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"LTBP4 is a secreted extracellular matrix glycoprotein that couples latent TGF-beta sequestration to elastic fiber assembly, functioning as both a structural ECM component and a local regulator of TGF-beta bioavailability [#0, #3]. It is secreted both free and as a disulfide-bonded complex with a TGF-beta LAP-like protein, with TGF-beta binding mediated by its third 8-cysteine (TB) module; an alternatively spliced variant lacking this module fails to bind TGF-beta, allowing cells to tune TGF-beta deposition independent of total expression [#0, #2]. ECM targeting depends on direct binding of the LTBP-4 N-terminal region to fibronectin, and loss of this targeting elevates TGF-beta activity [#5]. Genetic ablation in mice produces pulmonary emphysema, cardiomyopathy, and colorectal cancer with defective elastic fibers and reduced ECM TGF-beta deposition, where LTBP4 specifically enables TGF-beta1 activation (rather than secretion) and thereby restrains compensatory TGF-beta2/beta3 upregulation and BMP-4 signaling [#3, #4]; recessive loss-of-function mutations cause an analogous human disorder of failed ECM deposition, increased TGF-beta activity, and multi-organ elastic fiber defects [#7]. LTBP4's structural and TGF-beta-regulatory roles are genetically separable [#6]. The two isoforms generated from independent promoters are functionally distinct: LTBP-4L complexes with TGF-beta1 and is required for fibulin-4 incorporation into the matrix, whereas LTBP-4S is secreted largely free and is incorporated into the ECM [#8, #10]. Fibulin-4 multimers act as an extracellular chaperone, switching LTBP-4L from a compact to an elongated conformation that enhances fibronectin and fibrillin-1 binding and drives elastogenesis, while fibulin-5 performs the analogous conformational switch on LTBP-4S; N-linked glycans confer isoform-specific control of these axes, which act synergistically [#15, #21]. Beyond the matrix, LTBP4 has context-specific signaling roles, including a cardiomyocyte function in which it is recruited to the MTOC via dynein after angiotensin II stimulation to facilitate NLRP3-NEK7 interaction and inflammasome activation [#22].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing LTBP4's basic biochemistry answered whether it physically links TGF-beta to the ECM: it does, via a disulfide-bonded latent complex deposited into matrix and releasable by proteolysis.\",\n      \"evidence\": \"cDNA cloning, immunoblotting, ECM fractionation, and plasmin treatment of human lung fibroblast secretions\",\n      \"pmids\": [\"9660815\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the activating protease(s) in vivo not defined\", \"Domain mediating TGF-beta complexing not yet mapped\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Domain architecture clarified the structural basis for both functions, predicting microfibrillar/elastic roles and TGF-beta binding capacity.\",\n      \"evidence\": \"cDNA sequencing and Northern blot defining 20 EGF-like and 4 TB modules and tissue expression\",\n      \"pmids\": [\"9271198\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional reconstitution of predicted activities\", \"Which TB module binds TGF-beta not resolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Mapping TGF-beta binding to the third 8-Cys module showed how alternative splicing can decouple TGF-beta sequestration from total LTBP4 levels.\",\n      \"evidence\": \"RT-PCR identification of a splice variant and functional TGF-beta binding assay\",\n      \"pmids\": [\"11683420\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological prevalence and regulation of the splice variant unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Knockout phenotyping established LTBP4 as both an ECM structural component and a local restraint on TGF-beta signaling, linking its loss to emphysema, cardiomyopathy, and cancer.\",\n      \"evidence\": \"Gene-trap knockout mouse with histology, phospho-Smad2, and c-myc analyses\",\n      \"pmids\": [\"12208849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether structural vs signaling defects are separable not addressed here\", \"Mechanism of TGF-beta regulation (activation vs deposition) unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defining the step LTBP4 controls showed it is required for TGF-beta1 activation, not secretion, with downstream consequences for compensatory TGF-beta isoforms and BMP-4 signaling.\",\n      \"evidence\": \"Knockout fibroblast microarray, active TGF-beta assay, rescue transfection, and ligand rescue\",\n      \"pmids\": [\"15466481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which LTBP4 enables activation not defined\", \"LTBP-1 non-redundancy mechanism unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identifying fibronectin as the ECM-targeting receptor explained how LTBP4 reaches the matrix and how mistargeting elevates TGF-beta activity.\",\n      \"evidence\": \"Direct binding assays, heparin competition, and FN-null fibroblast analysis\",\n      \"pmids\": [\"18585707\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Heparin/proteoglycan partner identity in vivo unknown\", \"Relationship to fibrillin microfibrils not yet mapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Genetic dissection separated LTBP4's two roles, showing elastogenesis and TGF-beta modulation are independent functions; parallel human mutation studies confirmed both functions in human development.\",\n      \"evidence\": \"Ltbp4S-/- mice with TGF-beta2 knockdown and time-course analysis; patient fibroblast ECM deposition and TGF-beta activity assays\",\n      \"pmids\": [\"19016471\", \"19836010\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis distinguishing the two functions not resolved\", \"Spectrum of human phenotypes incompletely defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Resolving isoform behavior showed LTBP-4L and LTBP-4S differ in TGF-beta complexing and ECM targeting, arising from independent promoters.\",\n      \"evidence\": \"Promoter analysis, conditioned-medium/ECM fractionation, and immunofluorescence\",\n      \"pmids\": [\"20175115\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why LTBP-4L is poorly matrix-incorporated alone unexplained at this stage\", \"Tissue-specific functional division of labor untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identifying fibulin-4 as a partner of both isoforms, with LTBP-4L required for fibulin-4 matrix incorporation, linked LTBP4 to a specific elastogenic assembly node.\",\n      \"evidence\": \"Germline knockout comparison, Co-IP/pulldown, and ECM immunofluorescence\",\n      \"pmids\": [\"25713297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of fibulin-4 incorporation dependence unknown\", \"Structural basis of interaction not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"In vivo epistasis confirmed LTBP-4L and fibulin-4 act together as a requirement for survival and elastogenesis, and additional work tied LTBP4 to Nrf2/Keap1-PdgfrB regulation downstream of TGF-beta.\",\n      \"evidence\": \"Ltbp4S-/-;Fibulin-4R/R double mutants; Ltbp4S-/- pathway analysis with TGF-beta dependency\",\n      \"pmids\": [\"27585882\", \"27645114\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nrf2/Keap1 link is single-lab and mechanistically indirect\", \"How the LTBP-4L/fibulin-4 partnership executes elastogenesis still molecular-level open\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Mechanistic deconstruction of the lung phenotype showed septation defects arise from combined loss of elastic fibers, reduced angiogenesis, and excess TGF-beta-driven fibrosis.\",\n      \"evidence\": \"Ltbp4-/- lung morphometry, vascular analysis, TGF-beta activity assays\",\n      \"pmids\": [\"28684544\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of each mechanism not quantified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Reconstitution revealed the molecular mechanism of fibulin-4 action: as multimers it chaperones a compact-to-elongated conformational switch in LTBP-4L that enables matrix protein binding and elastogenesis.\",\n      \"evidence\": \"SEC-MALS, SAXS, Co-IP/pulldown, and cell-free tropoelastin assembly assays\",\n      \"pmids\": [\"31548410\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo timing of the conformational switch not visualized\", \"Whether LTBP-4S uses an analogous mechanism not yet tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Completing the dual-axis model, fibulin-5 was shown to drive an analogous conformational extension of LTBP-4S, with N-glycans conferring isoform-specific control of both axes.\",\n      \"evidence\": \"Glycoproteomics, deglycosylation, biophysical binding, and in vitro elastic fiber assembly assays\",\n      \"pmids\": [\"40608550\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo synergy of the two axes not genetically tested\", \"Glycosyltransferases responsible not identified\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"A non-canonical intracellular role was defined: LTBP4 is recruited to the MTOC via dynein and facilitates NLRP3-NEK7 inflammasome assembly in stressed cardiomyocytes.\",\n      \"evidence\": \"Cardiomyocyte-specific conditional knockout (TAC), Co-IP, MTOC immunofluorescence, and inflammasome activity assays\",\n      \"pmids\": [\"42140931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a secreted ECM protein accesses the cytoplasmic MTOC pool not explained\", \"Generality beyond cardiomyocytes untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How LTBP4's canonical extracellular elastogenic/TGF-beta functions mechanistically relate to its emerging intracellular and tissue-protective signaling roles (Hippo-YAP, renal mitochondrial/angiogenic, inflammasome) remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying mechanism connecting extracellular and intracellular pools\", \"Many context-specific signaling roles rest on single-lab studies\", \"Trafficking that diverts secreted LTBP4 to intracellular compartments undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [0, 2, 8]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [3, 6, 10, 15]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 7]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [0, 5, 8, 10]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 7]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [5, 7, 10, 15, 21]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4, 9]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [14, 22]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 7]}\n    ],\n    \"complexes\": [\"LTBP4-latent TGF-beta complex\"],\n    \"partners\": [\"TGFB1\", \"FN1\", \"FBLN4\", \"FBLN5\", \"FBN1\", \"ADAMTSL2\", \"DYNC1H1\", \"NLRP3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}